노보셀바이오

History

2023

·Completed development and commercialization of low-molecular amino acid extraction and processing technology
·Promotion of establishment of immune cell therapy center (Japan, Vietnam, etc.)

2022

·So Jin-il, CEO of Novocellbio Co., Ltd., received the 5th 13 people who made Korea shine in the "medicine category“
·Development of immune cell manufacturing method with improved cytotoxicity (Application No. 10-2022-0085308)
·Completed manufacturing facility for cell therapy production at TecSalud University Foundation Hospital in Mexico

2021

·Joint clinical trial and cooperation agreement with Mexican TecSalud consortium for technology export of ‘NOVO-NK’, a COVID-19 treatment
·Promotion of phase 1 clinical trial for anti-cancer drug development with Chung-Ang University
·Establishment of clinical and R&D GMP

2018 ~ 2020

·Method for increasing cell therapy viability (Patent application: 10-2018-0034464)
·Lymphocyte harvesting method using density gradient centrifugation (patent application: 10-2018-003448)
·Establishment of Fukuoka Immunotherapy Center in Japan
·Changed company name to Novocellbio Co., Ltd.

2017

·Relocated to Songdo, Incheon

Company

2015~2016

·Completed development of reagents for cytotoxic activation and NK cell culture (more than 97% of NK cells possible)
·Completed research and development of NK cell mass proliferation (more than 60% of NK cell ratio possible)

2013~2014

·Development of immune cell culture technology and technology development to improve product toxicity, cell number, and purity
·Research on natural substances and proteins for the development of new culture technologies

2012

·Establishment of a corporate affiliated research institute
·Started research and development of immune cell therapy

2003~2011

·Incorporation of a corporation
·Advancement into biopharmaceuticals and research reagent development research and equipment distribution business

Manpower

Management Board

President

Mr. Soh, Jin Il

·Hanyang Univeristy-Department of Trading.
·Halla Cement-Overseas sales Team
·Koreasensor.Com Co.,LTD(C.E.O)
·CoreLBT Co.,LTD(Chairman)

Vice President

Mr. Shin, Moon Sun

·Yonsei University – Department of Business Administration,
·LG Electronics America Corporation (CFO)
·LG Electronics (Managing Director, IT)
·LS Asset Management (CFO)
·LS Global (CEO)

Director

Mr. Kim, Seon Mo

·Korea University of Foreign Studies-Department of English
·Dai Loc Co.,Ltd(Director of Investment Planning Department)
·Naru Tech Co., Ltd. (Director of Overseas Business Division)
·CoreLBE Co.,Ltd(C.E.O)

R&D Staff

Research Director

Ms. Moon Guy Young

General management of cell therapy development

·Dongduk Women University(Master of Dept. of Pharmacy)
·Achieved Oriental Pharmacist Certification
·Sung Do pharmaceutical co., Ltd(Director)
·CoreLBT Co.,LTD(R&D Director)
·Research Director of Novocell Bio Co., Ltd.

Senior Researcher

Mr. Lee Jae Won

Cell therapy development

·Hanyang University College of Medicine(MD/Thoracic surgery specialist)
·Eulji Medical University(Professor, Dept. of Medicine)
·Youngguang Hospital(Chairman)
·Member of Korean Medical Association, Korean society for thoracic and cardiovascular surgery
·Korean society for Vascular surgery

Principal Researcher

Ms. Back A Rome

Research and development of immune cell therapy

·Graduated from Department of Pharmacology, Hallym University
·Researcher at the National Cancer Center
·Senior researcher of Rescue Bioscience Co., Ltd.
·Principal Researcher of Novocell Bio Co., Ltd.

Researcher

Mr. Lee Jae Min

Immune cell research

·Master's degree in Molecular Biology, Chung-Ang University
·Researcher of Novocell Bio Co., Ltd.

Low-molecular Amino acids

Research Director

Mr. Kim Ho Won

Low-molecular Amino acids

·Doctor of Public Health, Wonkwang University
·Wonkwang University Professor
·Director of Wonkwang Sports Medicine Research Institute
·Chairman of the Agricultural Life Industry Cooperative
·CEO of Wonkwang Biosystems Co., Ltd.

Research Associate Director

Ms. Choi Eun Young

Low-molecular Amino acids

·PhD in Food and Nutrition,Wonkwang University
·Wonkwang University Industry-University Cooperation Foundation Full-time Researcher
·Iksan Agricultural Technology Center Instructor
·ofessor, Department of Food and Nutrition, Wonkwang University
·Professor,Department of Food Processing, Chonbuk National University

Patent & Technology

Category	Main Content
Patent	·Antiviral composition containing NK cells as an active ingredient (Application No.: 10-2020-0132050) ·Method for manufacturing immune cells with improved cytotoxicity (Application No.: 10-2023-0011635) ·Method for manufacturing immune cells with improved cytotoxicity (International PCT application: KR 2023/002414)
Technologies	·Cytotoxic activation and NK cell mass proliferation culture technology ·NK cell ratio up to 99% or more, NK cell number more than 2 billion culture technology ·Various activation receptor expression and high cytotoxicity expression technology

Overview

President

Mr. SOH,JIN IL
Established

1st November 2003
Address

8th, Aniocean B/D, 99, Incheon Tower-Darero, Yeonsu-Gu, Incheon, Republic of Korea
Capital

KRW 17,925,000,000
Staff

30 persons
Contact

TEL : 032-723-9988
FAX : 032-723-9977
Website

www.novocellbio.com